Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.72 |
| ▸ | CA12 | O43570 | 5/20 | 0.71 |
| ▸ | CA7 | P43166 | 5/20 | 0.71 |
| ▸ | CA9 | Q16790 | 5/20 | 0.71 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.71 |
| ▸ | CA1 | P00915 | 4/20 | 0.71 |
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | ESR1 | P03372 | 1/20 | 0.68 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.66 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.66 |
| ▸ | CA4 | P22748 | 3/20 | 0.66 |
| ▸ | CA6 | P23280 | 3/20 | 0.66 |
| ▸ | CA5A | P35218 | 3/20 | 0.66 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.66 |
| ▸ | MET | P08581 | 1/20 | 0.66 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.62 |
| ▸ | MAOB | P27338 | 1/20 | 0.61 |
| ▸ | TYR | P14679 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10007931 | 1.00 | APP (0.72) | APPCA12CA7CA9CA14 | |
| Methane SCHEMBL27971068 | 0.98 | APP (0.70) | APPCA12CA7CA9CA14 | |
| SCHEMBL13877797 | 0.96 | APP (0.67) | APPCA12CA7CA9CA14 | |
| SCHEMBL5548014 | 0.95 | APP (0.72) | APPCA12CA7CA9CA14 | |
| SCHEMBL5548013 | 0.95 | APP (0.72) | APPCA12CA7CA9CA14 | |
| SCHEMBL6397881 | 0.94 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL21001200 | 0.94 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL28630704 | 0.94 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL19359004 | 0.94 | APP (0.73) | APPCA12CA7CA9CA14 | |
| SCHEMBL10299697 | 0.94 | APP (0.73) | APPCA12CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102883753-A | Drug-releasing coatings for medical devices | LUTONIX INC | 2013-01-16 | — | — | CN | claimed |
| CN-87107947-A | hot fumigator | — | 1988-08-31 | — | — | CN | claimed |
| CN-107602383-B | Method for preparing p-hydroxycinnamate by catalyzing lignin with ionic liquid | 华南理工大学 | 2020-11-24 | — | — | CN | disclosed |
| US-10807940-B2 | Method for preparing p-hydroxycinnamate by using ionic liquid for catalytic lignin depolymerization | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2020-10-20 | — | — | US | disclosed |
| US-20200181058-A1 | Method for Preparing P-Hydroxycinnamate by Using Ionic Liquid for Catalytic Lignin Depolymerization | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2020-06-11 | — | — | US | disclosed |
| CN-108424683-A | Solventbased inkjet ink composition | 内蒙古显鸿科技股份有限公司 | 2018-08-21 | — | — | CN | disclosed |
| EP-2479170-B1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, AND ORIENTED FILM | NISSAN CHEMICAL IND LTD (JP) | 2018-01-03 | — | — | EP | disclosed |
| CN-104857573-A | Drug releasing coating for medical device | LUTONIX INC | 2015-08-26 | — | — | CN | disclosed |
| CN-102883753-B | Drug-releasing coatings for medical devices | LUTONIX INC | 2015-04-15 | — | — | CN | disclosed |
| CN-102630225-B | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and oriented film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-10-01 | — | — | CN | disclosed |
| WO-2014105405-A1 | ANTIOXIDANTS FOR USE IN SOLVENT EXTRACTION SYSTEMS | FLSMIDTH A/S (DK) | 2014-07-03 | — | — | WO | disclosed |
| WO-2003085017-A1 | PRODUCTION OF POLYOXYMETHYLENE AND SUITABLE (II) CATALYSTS | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-16 | — | — | WO | disclosed |
| WO-2003085016-A1 | PRODUCTION OF POLYOXYMETHYLENE AND SUITABLE (III) CATALYSTS | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-16 | — | — | WO | disclosed |
| EP-1124891-A1 | POLYETHERIMIDE RESIN/POLYESTER RESIN BLENDS | GENERAL ELECTRIC COMPANY (US) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000012604-A1 | POLYETHERIMIDE RESIN/POLYESTER RESIN BLENDS | GENERAL ELECTRIC COMPANY (US) | 2000-03-09 | — | — | WO | disclosed |
| EP-0372728-A2 | Smoothly removable cover tape for electronic component carrier | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1990-06-13 | — | — | EP | disclosed |
| EP-0266994-A2 | Process for the grafting of monomers onto polymers | Du Pont Canada Inc. (CA) | 1988-05-11 | — | — | EP | disclosed |
| US-4066589-A | ZWITTERIONIC POLYMER, NON-IRRITATING | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-01-03 | — | — | US | disclosed |
| US-4035506-A | Fluorocarbon dermal protective compositions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1977-07-12 | — | — | US | disclosed |
| US-3953398-A | 3,5-DI-TERT-ALKYL-4-HYDROXYCINNAMIC ACID OR ESTER AS STABILIZER | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10807940-B2 | Method for preparing p-hydroxycinnamate by using ionic liquid for catalytic lignin depolymerization | HACL2, HPD, HLCS | APP 4539/4885CA12 3829/4885CA7 2123/4885 |
| US-20200181058-A1 | Method for Preparing P-Hydroxycinnamate by Using Ionic Liquid for Catalytic Lignin Depolymerization | HACL2, HPD, HLCS | APP 4539/4885CA12 3829/4885CA7 2123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.